U.S. Urology Partners Expands with General Atlantic Investment
Deal News | Apr 09, 2025 | General Atlantic
U.S. Urology Partners, a comprehensive platform that supports independent, community-based urology groups, has announced a significant growth investment from General Atlantic. This investment marks a new stage of expansion for U.S. Urology Partners, previously supported by NMS Capital. With this financial boost, the Company aims to strengthen its capabilities in providing premier care while maintaining independent operations for its affiliates across various locations in the United States, such as Florida, Indiana, Massachusetts, New York, and Ohio. The partnership with General Atlantic will allow U.S. Urology Partners to enhance its business operations, data insights, and technology infrastructure and to invest further in both oncology and non-oncology clinical capabilities. The transaction led to the exit of NMS Capital from its partnership, while also welcoming General Atlantic's Robbert Vorhoff and Jon Michael Reese to the Company's Board of Directors. Financial and legal advice for the transaction was provided by Houlihan Lokey, Ernst & Young Capital Advisors, and McDermott Will & Emery.
Sectors
- Healthcare
- Private Equity
- Financial Advisory Services
- Legal Services
Geography
- United States – U.S. Urology Partners operates its services across several states including Florida, Indiana, Massachusetts, New York, and Ohio, and the investment is from General Atlantic, a global firm with a significant presence in the U.S.
Industry
- Healthcare – The investment supports a company deeply involved in providing comprehensive management solutions for urology practices, aiming to enhance patient care in community-based settings across various healthcare specialties.
- Private Equity – General Atlantic's investment in U.S. Urology Partners represents a transaction that leverages PE firm strategies to scale innovative healthcare provider organizations.
- Financial Advisory Services – Houlihan Lokey and Ernst & Young Capital Advisors acted as financial advisors in the transaction, providing specialized financial advisory services to the involved entities.
- Legal Services – McDermott Will & Emery provided legal counsel to the parties, which is an essential aspect of completing investment transactions.
Financials
- Not disclosed – The specific terms and financial details of the investment by General Atlantic in U.S. Urology Partners have not been disclosed.
- $103 billion – General Atlantic manages approximately $103 billion in assets under management as of December 31, 2024.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| U.S. Urology Partners | Target | Company | A comprehensive platform supporting community-based urology practices to deliver quality patient care. |
| General Atlantic | Investor | Company | A leading global private equity firm investing in growth companies across multiple sectors. |
| NMS Capital | Selling Company | Company | Former partner of U.S. Urology Partners, exiting the investment as General Atlantic steps in. |
| Houlihan Lokey | Financial Advisor | Company | Provided financial advisory services to U.S. Urology Partners and NMS Capital for the transaction. |
| Ernst & Young Capital Advisors | Financial Advisor | Company | Served as financial advisor alongside Houlihan Lokey for the transaction. |
| McDermott Will & Emery | Legal Advisor | Company | Provided legal counsel to U.S. Urology Partners and NMS Capital during the transaction. |
| Corina Tracy | CEO | Person | The CEO of U.S. Urology Partners overseeing its strategic growth and operations. |
| Robbert Vorhoff | Board Member | Person | Managing Director and Global Head of Healthcare at General Atlantic; joining the Board of U.S. Urology Partners post-investment. |
| Jon Michael Reese | Board Member | Person | Principal at General Atlantic; joining the Board of U.S. Urology Partners post-investment. |